arrow
A

Atsushi Nakajima

international university of health and welfare atami hospital
H指数:89
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative diagnostic performance of ultrasound-guided attenuation parameter versus B-mode scoring for hepatic steatosis assessment: an ordinal-scale statistical approach

超声引导下衰减参数与B模式评分对肝脂肪变评估的对比诊断性能:一种序数尺度统计方法

2026-04-020
PRE
Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational Study
2026-01-290
PRE
Bali Chronic Constipation Roundtable Report: Chronic Constipation Management in Asia

巴厘慢性便秘圆桌会议报告:亚洲慢性便秘管理

2026-01-010
OA
Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement

代谢功能障碍相关脂肪性肝病且FIB-4与肝硬度测量结果不一致患者的组织学严重程度和肝脏结局

2026-01-011
PRE
Cardiovascular-kidney-metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD

心血管-肾脏-代谢综合征与MASLD患者肝纤维化进展及肝脏相关事件的风险

2025-12-010
PRE
Variations in Estimated Glomerular Filtration Rate Across Countries in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Their Association With Liver Fibrosis: A Multicenter Study

代谢功能障碍相关脂肪性肝病患者的估算肾小球滤过率在国家间的差异及其与肝纤维化的关联:一项多中心研究

MEDCOMM
IF10.7
2025-11-240
OAAI
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study

Younossi, Z.M.; de Avila, L.; Petta, S.; Hagström, H.; Kim, S.U.; Nakajima, A.; Crespo, J.; Castera, L.; Alkhouri, N.; Zheng, M.H.; 等. MASLD的纤维化、临床事件及死亡率的预测因素:全球MASLD研究的数据. 肝病学 2025. [Google Scholar] [CrossRef]

2025-11-013
PRE
Impact of MELD 3.0 on Waitlist Outcomes of Metabolic Dysfunction-Associated Steatohepatitis Cirrhosis Among Liver Transplant Candidates

MELD 3.0对代谢功能障碍相关脂肪性肝炎肝硬化等待移植患者等待名单结局的影响

2025-10-250
PRE
Meta-Analysis: Utilisation of Hepatocellular Carcinoma Surveillance

Meta-Analysis: 肝细胞癌筛查的应用

2025-10-120
PRE
Long-Term Glycemic Control and the Risk of Liver Stiffness Progression and Liver-Related Events in MASLD

长期血糖控制与肝硬度进展及肝脏相关事件风险的关系 (MASLD)

2025-10-100
PRE
Association between longitudinal weight change and clinical outcome in individuals with MASLD

MASLD个体中纵向体重变化与临床结局的关联

2025-10-012
PRE
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study

非侵入性试验在MASLD中的全球表现:G-MASLD研究的见解

2025-10-010
PRE
Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-Analysis

代谢功能障碍相关脂肪性肝病中肝细胞癌的发生率:一项重建的个体患者数据荟萃分析

2025-09-090
PRE
Effect of Hypertension on Long-term Adverse Clinical Outcomes and Liver Fibrosis Progression in MASLD

高血压对长期不良临床结局及MASLD患者肝纤维化进展的影响

2025-08-230
PRE